The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Requirement for ERK Activation in Cisplatin-induced Apoptosis
Open accessAbstract
Cisplatin activates multiple signal transduction pathways involved in coordinating cellular responses to stress. Here we demonstrate a requirement for extracellular signal-regulated protein kinase (ERK), a member of the mitogen-activated protein kinase family in mediating cisplatin-induced apoptosis of human cervical carcinoma HeLa cells. Cisplatin treatment resulted in dose- and time- dependent activation of ERK. That elevated ERK activity contributed to cell death by cisplatin was supported by several observations: 1) PD98059 and U0126, chemical inhibitors of the MEK/ERK signaling pathway, prevented apoptosis; 2) pretreatment of cells with TPA, an activator of the ERK pathway, enhanced their sensitivity to cisplatin; 3) suramin, a growth factor receptor antagonist that greatly suppressed ERK activation, likewise inhibited cisplatin-induced apoptosis; and, finally, 4) HeLa cell variants selected for cisplatin resistance showed reduced activation of ERK following cisplatin treatment. Cisplatin-induced apoptosis was associated with cytochrome c release and subsequent caspase-3 activation, both of which could be prevented by treatment with the MEK inhibitors. However, the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone protected HeLa cells against apoptosis without affecting ERK activation. Taken together, our findings suggest that ERK activation plays an active role in mediating cisplatin-induced apoptosis of HeLa cells and functions upstream of caspase activation to initiate the apoptotic signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Self-citationOpposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Self-citationAlessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393
Zou, H., Henzel, W. J., Liu, X., Lutschg, A., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80501-2 · Cited by 3,145
Self-citationIdentification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,015
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9
Zou, H., Li, Y., Liu, X., & Wang, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11549 · Cited by 2,090
Self-citationTransformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., & Ahn, N. G. (1994) · Science · doi:10.1126/science.8052857 · Cited by 1,353
Cryns, V., & Yuan, J. (1998) · Genes & Development · doi:10.1101/gad.12.11.1551 · Cited by 1,228
Activation of Mitogen-activated Protein Kinase by H2O2
Guyton, K. Z., Liu, Y., Gorospe, M., Xu, Q., & Holbrook, N. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4138 · Cited by 1,212
Self-citationAn Induced Proximity Model for Caspase-8 Activation
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2926 · Cited by 1,023
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ Radiation
Chen, Y.-R., Wang, X., Templeton, D., Davis, R. J., & Tan, T.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31929 · Cited by 867
Self-citationMitochondrial control of apoptosis: the role of cytochrome c
Cai, J., Yang, J., & Jones, D. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00109-1 · Cited by 768
WANG, X., MARTINDALE, J. L., LIU, Y., & HOLBROOK, N. J. (1998) · Biochemical Journal · doi:10.1042/bj3330291 · Cited by 736
Self-citationAikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, Y., & Yazaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119709 · Cited by 687
Thomas, S. M., DeMarco, M., D'Arcangelo, G., Halegoua, S., & Brugge, J. S. (1992) · Cell · doi:10.1016/0092-8674(92)90075-n · Cited by 676
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
Chu, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42175-2 · Cited by 651
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda, S., Sieverts, H., Friesen, C., Herr, I., & Debatin, K. (1997) · PubMed · Cited by 482
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464
Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F.-F., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00547-x · Cited by 444
Cellular and molecular determinants of cisplatin resistance
Perez, R. P. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00227-5 · Cited by 384
Sequential protein kinase reactions controlling cell growth and differentiation
Johnson, G. L., & Vaillancourt, R. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90141-4 · Cited by 335
Brenner, B., Koppenhoefer, U., Weinstock, C., Linderkamp, O., Lang, F., & Gulbins, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22173 · Cited by 297
Troppmair, J., Bruder, J. T., Munoz, H., Lloyd, P. A., Kyriakis, J., Banerjee, P., Avruch, J., & Rapp, U. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37478-1 · Cited by 240
Persons, D. L., Yazlovitskaya, E. M., Cui, W., & Pelling, J. C. (1999) · PubMed · Cited by 237
Cisplatin induces a persistent activation of JNK that is related to cell death
Sánchez-Perez, I., Murguía, J. R., & Perona, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201578 · Cited by 236
Sutherland, C. L., Heath, A. W., Pelech, S. L., Young, P. R., & Gold, M. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3381 · Cited by 235
Zanella, C. L., Posada, J. A., Tritton, T. R., & Mossman, B. T. (1996) · PubMed · Cited by 230
Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., & Mercola, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14041 · Cited by 229
p27Kip1 overexpression causes apoptotic death of mammalian cells
Wang, X., Gorospe, M., Huang, Y., & Holbrook, N. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201450 · Cited by 221
Self-citationSasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., & Yodoi, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118668 · Cited by 201
Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H., Mercola, D., & Murata, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31648 · Cited by 175
Miyajima, A., Nakashima, J., Yoshioka, K., Tachibana, M., Tazaki, H., & Murai, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.363 · Cited by 170
Modulation of cis-diamminedichloroplatinum(II) resistance: a review
Timmer-Bosscha, H., Mulder, N., & de Vries, E. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.249 · Cited by 164
Graves, J. D., Draves, K. E., Craxton, A., Saklatvala, J., Krebs, E. G., & Clark, E. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13814 · Cited by 161
Chen, W., Martindale, J. L., Holbrook, N. J., & Liu, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5178 · Cited by 152
Self-citationCisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA.
Chu, G., & Chang, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3324 · Cited by 139
Lack of c‐Jun activity increases survival to cisplatin
Sánchez‐Pérez, I., & Perona, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00690-0 · Cited by 95
Dixit, M., Yang, J.-L., Poirier, M. C., Price, J. O., Andrews, P. A., & Arteaga, C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.365 · Cited by 74
El‐Shemerly, M., Besser, D., Nagasawa, M., & Nagamine, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30599 · Cited by 71
Kaneki, M., Kharbanda, S. M., Pandey, P., Yoshida, K., Takekawa, M., Liou, J.-R., Stone, R. M., & Kufe, D. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.461 · Cited by 69
Oxidative Stress Activates the Human Histidine Decarboxylase Promoter in AGS Gastric Cancer Cells
Höcker, M., Rosenberg, I. M., Xavier, R. J., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23046 · Cited by 64
He, H., Wang, X., Gorospe, M., Holbrook, N. J., & Trush, M. A. (1999) · PubMed · Cited by 43
Self-citationZhou, H., Lin, A., Gu, Z., Chen, S., Park, N.-H., & Chiu, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909273199 · Cited by 25
Gao, X., Asaumi, J., Kawasaki, S., Nishikawa, K., Kuroda, M., Takeda, Y., Hiraki, Y., Ihara, M., & Ohnishi, T. (1995) · PubMed · Cited by 15
Cited by
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Metadata
- Authors
- Wang, X., Martindale, J. L., & Holbrook, N. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 50
- Pages
- 39435-39443
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2021736277
- Cited by
- 675
- References
- 51
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.